Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Nephros (NEPH) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical Instruments & SuppliesNEPH

Closing price · Nov 19, 2026 $2.88 -0.3% on the day · -42.7% over 12 months 52-week range $2.78 – $5.79
Get NEPH alerts
Open-market purchases1 insider$15K · last 12 months
Insiders selling0last 12 months
Reported sales$0last 12 months
In 15 seconds

Insiders put their own money in: $15K of open-market buys. See how similar setups did below.

Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • 90-day result for Arthur H. Amron's $22K buy: in on Feb 16, 2027. See the 7- and 30-day results ↓
  • Next earnings expected around Feb 8, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Purchase Arthur H. Amron, Director bought 5,000 shares at $3.00 ($15K).

Trade date
Nov 16, 2026
Disclosed to the SEC
Nov 18, 2026
Type
Open-market purchase (code P)

Read the original SEC filing ↗All NEPH insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

NEPH insider transactions (Form 4)

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Nov 18SEC Arthur H. AmronDirectorFirst buy in 2 yrs Buy 5,000167,137 held (+3%) $3.00 $15K -3.8% —
Nov 18SEC Arthur H. AmronDirectorFirst buy in 2 yrs Buy 2,500169,637 held (+1%) $2.84 $7K +1.4% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for NEPH's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with NEPH in the Research Lab

Pre-set to NEPH's latest insider buy of $10K or more (Nov 18, 2026: Arthur H. Amron, $15K). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

NEPH closeInsider buyInsider sale
23456DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-05-07EEarnings release filed 2026-08-06EEarnings release filed 2026-11-05Bought $7,100 on 2026-11-17 · Arthur H. AmronBought $14,975 on 2026-11-16 · Arthur H. Amron
Bought, 12 months$15K
Sold, 12 months$0
Insiders buying1
Insiders selling0

Nephros insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $15K and 0 sold $0 of NEPH stock on the open market; P/E 16.6 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this

NEPH insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2026: $22K bought (2 trades)$22KQ4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$22K2—0

Valuation, profit and volume

P/E (trailing)16.6Sector median 25.0
Market value$30.7MMedical Instruments & Supplies
Profit margin8.9%Revenue growth +18.0%
Volume vs. 50-day1.8×Last 5 sessions
Insiders' paper profit−$470On all tracked purchases -2.1%

Source: Yahoo Finance, as of Nov 19, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 NEPHROS INC insider reported open-market purchases totaling $15K, while 0 insiders reported sales totaling $0.

NEPH earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 5, 2026 -7.7% None -14.2%S&P -4.1% pending
Aug 6, 2026 -0.3% None +17.6%S&P +0.5% -3.6%
May 7, 2026 +12.2% None +9.3%S&P +0.5% -2.8%
Aug 11, 2025 +13.4% None +9.2%S&P +0.9% -1.2%
May 8, 2025 +3.2% None -2.6%S&P +0.6% +76.8%
Mar 6, 2025 -3.9% None +13.0%S&P -1.2% +23.6%
Nov 13, 2024 +17.1% None -3.7%S&P -0.6% -1.9%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

NEPH stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after NEPH insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Nov 18, 2026Arthur H. AmronDirector$22K pendingpendingpending

Insiders at NEPHROS INC

InsiderBoughtSoldLast filingPast buys beat S&PScore
Arthur H. AmronDirector $22K — Nov 18, 2026 — —

Board links: companies that share insiders with NEPH

Directors and executives who filed Form 4s for NEPH and another company in the last 12 months.

See the map →
  • TUSKMammoth Energy Services Arthur H. Amron Director here · Director at TUSK · latest filing Nov 18, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

NEPH stock: common questions

Are NEPHROS INC insiders buying NEPH stock?

In the past 12 months, 1 insider reported open-market purchases of NEPH worth $15K. The latest was Director Arthur H Amron bought $15K of NEPH at $3.00 — first open-market purchase in our records.

Are NEPHROS INC insiders selling NEPH stock?

No. No NEPHROS INC insider reported an open-market sale of NEPH in the past 12 months.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is NEPH's P/E ratio?

NEPH trades at about 16.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is NEPH's 52-week range?

Over the past year NEPH has traded between $2.78 and $5.79. It last closed at $2.88 on Nov 19, 2026.